Infinium Pharmachem Limited — Important, 10-01-2025: Updates

The company has confirmed that it is exempt from submitting the Report on Corporate Governance for the quarter ended December 31, 2024, as its equity shares are listed on the SME exchange. This exemption is in accordance with the specified regulations. This lack of governance reporting is typical for SMEs and does not inherently impact the company's operational transparency or investor confidence. Stakeholders can view this clarity in regulatory compliance as a neutral indicator, but it's advisable to monitor any future changes in governance requirements that could affect the firm's reporting practices.